Prevention of Cardiovascular Disease
Author:
Open Access
- 1 February 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (2) , 423-431
Abstract
Perspectives on the News commentaries are now part of a new, free monthly CME activity. The Mount Sinai School of Medicine, New York, New York, is designating this activity for 2.0 AMA PRA Category 1 credits. If you wish to participate, review this article and visit www.diabetes.procampus.net to complete a posttest and receive a certificate. The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Keywords
This publication has 31 references indexed in Scilit:
- Effect of Various Diuretic Treatments on Rosiglitazone-Induced Fluid RetentionJournal of the American Society of Nephrology, 2006
- Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidenceBMJ, 2006
- Improvement of Glycemic Control, Triglycerides, and HDL Cholesterol Levels With Muraglitazar, a Dual (α/γ) Peroxisome Proliferator–Activated Receptor Activator, in Patients With Type 2 Diabetes Inadequately Controlled With Metformin MonotherapyDiabetes Care, 2006
- Revised Adult Treatment Panel III Guidelines and Cardiovascular Disease Mortality in Men Attending a Preventive Medical ClinicCirculation, 2005
- Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)American Journal of Kidney Diseases, 2005
- Physical activity decreases cardiovascular disease risk in womenAmerican Journal of Preventive Medicine, 2004
- Thiazolidinediones and Blood Lipids in Type 2 DiabetesArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Primary Prevention of Coronary Heart Disease in Women through Diet and LifestyleNew England Journal of Medicine, 2000
- Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 DiabetesDiabetes Care, 1998
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987